The risk reward potential has done a total 180 now. I previously thought a $20 to $30 million market cap was fair given the pharma silence. That has changed with the filings of patents. This is real now. Most people don't know that the there is a US patent on CBD, it is aninteresting read.
Look at what happened to VTGN...
I had bought private placement before the last reverse split so I feel your pain. Recently a friend of mine had a bizarres experience, we both have multiple companies that we bought and turned out to be zeros long forgotton. He recently got a call to vote his shares on a matter the Company was trying to get approved, he laughed and said his shares were worthless from 10 years ago. well, recently a new management team in the oild and gas sector took over the company unbeknownst to him, and he was shocked to find out his worthless shares were worth almost $200,000 and the stock trades volume.
The pharma portion of TAUG could make it a billion dollar market cap if successful. It could also fail. It could also fail and be reworked like VTGN is doing.
Regardless, the retail side could be worth a whole lot more than what I estimated.